NIBEC Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for NIBEC.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth72.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

More Unpleasant Surprises Could Be In Store For NIBEC Co., Ltd.'s (KOSDAQ:138610) Shares After Tumbling 34%

Nov 13
More Unpleasant Surprises Could Be In Store For NIBEC Co., Ltd.'s (KOSDAQ:138610) Shares After Tumbling 34%

Does NIBEC (KOSDAQ:138610) Have A Healthy Balance Sheet?

Oct 14
Does NIBEC (KOSDAQ:138610) Have A Healthy Balance Sheet?

Is NIBEC (KOSDAQ:138610) Weighed On By Its Debt Load?

Jun 18
Is NIBEC (KOSDAQ:138610) Weighed On By Its Debt Load?

NIBEC Co., Ltd.'s (KOSDAQ:138610) Share Price Not Quite Adding Up

Mar 28
NIBEC Co., Ltd.'s (KOSDAQ:138610) Share Price Not Quite Adding Up

NIBEC (KOSDAQ:138610) Has Debt But No Earnings; Should You Worry?

Apr 05
NIBEC (KOSDAQ:138610) Has Debt But No Earnings; Should You Worry?

NIBEC (KOSDAQ:138610) Has Rewarded Shareholders With An Exceptional 411% Total Return On Their Investment

Jan 04
NIBEC (KOSDAQ:138610) Has Rewarded Shareholders With An Exceptional 411% Total Return On Their Investment

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NIBEC has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A138610 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202419,407-4,843-7,915-2,536N/A
3/31/202417,578-5,890-11,153-3,817N/A
12/31/202315,704-6,284-9,640-1,960N/A
9/30/202316,213-11,668-8,245-857N/A
6/30/202317,493-8,157-5,328-60N/A
3/31/202318,878-5,1632,8635,648N/A
12/31/202221,670-3,7663,5945,440N/A
9/30/202220,077-6783,6856,651N/A
6/30/202220,776-8465,3327,687N/A
3/31/202218,766-3,340-8311,714N/A
12/31/202113,625-5,740-2,396818N/A
9/30/202112,682-4,419-3,342-644N/A
6/30/20219,383-5,519-5,022-1,868N/A
3/31/20217,225-4,834-5,591-2,066N/A
12/31/20206,357-3,638-4,935-502N/A
9/30/20206,775-2,314-6,043160N/A
6/30/20207,971-1,830-5,677298N/A
3/31/20208,949-2,235-5,206872N/A
12/31/20199,287-2,727-5,219-868N/A
9/30/20197,803-3,589-4,951-2,339N/A
6/30/20196,664-4,022-4,769-2,103N/A
3/31/20195,717-4,021-4,486-2,328N/A
12/31/20185,208-4,146-4,887-2,307N/A
9/30/20185,085-4,556-4,480-2,163N/A
6/30/20185,326-4,127-4,434-1,650N/A
3/31/20185,223-3,406N/A-1,279N/A
12/31/20176,303-2,568N/A563N/A
9/30/20176,219-1,683N/A2,279N/A
6/30/20175,890-2,383N/A513N/A
3/31/20175,849-2,280N/A1,306N/A
12/31/20164,804-3,027N/A-372N/A
9/30/20164,589-2,823N/A-967N/A
6/30/20164,600-2,354N/A-879N/A
3/31/20164,645-2,586N/A-1,982N/A
12/31/20154,174-2,426N/A-2,134N/A
9/30/20153,915-2,317N/A-1,469N/A
6/30/20154,010-2,553N/A-895N/A
3/31/20154,073-2,957N/A-944N/A
12/31/20144,786-3,621N/A-904N/A
9/30/20144,886-4,663N/A-1,791N/A
6/30/20144,386-4,608N/A-2,096N/A
3/31/20143,372-4,328N/A-1,850N/A
12/31/20132,272-3,850N/A-1,815N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A138610's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A138610's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A138610's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A138610's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A138610's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A138610's Return on Equity is forecast to be high in 3 years time


Discover growth companies